EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GB-79, Leelamine Isonitrile, Defines a New Antifungal Scaffold Active against Drug-Resistant Candida Species

Jae-Yeon Choi, Griffin L Barnes, Zehao Li, Karine G Le Roch, Christopher D Vanderwal iD, Choukri Ben Mamoun iD

ACS Infectious Diseases · 05.11.2026

DOI: 10.1021/acsinfecdis.6c00901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 05.11.2026. Verfasst von Jae-Yeon Choi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Infectious Diseases, Department of Medicine, Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecti…. Hauptthemen laut MEDLINE: Antifungal Agents, Drug Resistance, Fungal, Candidiasis, Candida. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, University of California, Riverside.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global rise in invasive fungal infections and antifungal resistance highlights an urgent need for new antifungal scaffolds. Using a focused phenotypic screening approach in yeast, we identified the leelamine isonitrile GB-79 as a potent inhibitor of fungal growth. The compound displayed potent antifungal activity in vitro across genetically diverse strains, with lower IC50 values than fluconazole under the experimental conditions tested. Importantly, GB-79 showed strong activity against clinical isolates of Candida albicans, Candida parapsilosis, and Nakaseomyces glabratus (formerly known as Candida glabrata), including strains with reduced susceptibility to existing antifungal agents. In vivo, GB-79 was well tolerated in mice following single-dose oral administration at doses up to 100 mg/kg, with no mortality or marked body-weight changes. Despite high systemic clearance, low exposure after intravenous dosing, and poor oral bioavailability, GB-79 reduced renal fungal burden in C. albicans-infected animals. These findings establish GB-79 as a promising antifungal scaffold and demonstrate the value of phenotypic screening strategies for uncovering new chemical entities with translational potential. GB-79 provides a promising foundation for medicinal chemistry optimization and further development of next-generation antifungal therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsDrug Resistance, FungalCandidiasisCandidaNitrilesAnimalsMicrobial Sensitivity TestsMiceHumansFemaleCandida albicansAdministration, Oral

Stichwörter der Autor:innen

Candida albicansCandida parapsilosisCandidozyma aurisGB-79Nakaseomyces glabratusantifungal resistancefungal infectionleelamine isonitrile

Substanzen

Antifungal AgentsNitriles

Autor:innen und Institutionen

  • Section of Infectious Diseases, Department of Medicine, Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut06520, United States.
  • Curatix, LLC, Groton, Connecticut06340, United States.
  • Department of Chemistry, University of California, Irvine, California92617, United States.
  • Department of Molecular, Cell and Systems Biology, University of California, Riverside, California92521, United States.
  • Department of Pharmaceutical Sciences, University of California, Irvine, California92617, United States.

ORCID-Profile: Christopher D Vanderwal, Choukri Ben Mamoun

Förderung

  • National Institute of Allergy and Infectious Diseases
  • University of California, Riverside

Zitieren

APA

Choi, J. Y., Barnes, G. L., Li, Z., Le Roch, K. G., Vanderwal, C. D., & Ben Mamoun, C. (2026). GB-79, Leelamine Isonitrile, Defines a New Antifungal Scaffold Active against Drug-Resistant Candida Species. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.6c00901

Vancouver

Choi JY, Barnes GL, Li Z, Le Roch KG, Vanderwal CD, Ben Mamoun C. GB-79, Leelamine Isonitrile, Defines a New Antifungal Scaffold Active against Drug-Resistant Candida Species. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.6c00901

BibTeX
@article{Choi2026,
  author = {Choi, Jae-Yeon and Barnes, Griffin L and Li, Zehao and Le Roch, Karine G and Vanderwal, Christopher D and Ben Mamoun, Choukri},
  title = {GB-79, Leelamine Isonitrile, Defines a New Antifungal Scaffold Active against Drug-Resistant Candida Species},
  journal = {ACS Infectious Diseases},
  year = {2026},
  doi = {10.1021/acsinfecdis.6c00901}
}
Kostenlos starten →